Neurexis Therapeutics Works to Solve an Unmet Healthcare Need

CBSA President & CEO, Jennifer Jones Paton, asked Michael Artinger, PhD, Neurexis’ Chief Executive Officer, CBSA’s Key Questions for Life Sciences Innovators.

Neurexis-Therapeutics-Works-to-Solve-an-Unmet-Healthcare-Need_FINAL-1

 

Technology Solutions For A Better World

Our mission is to form and grow life science and emerging technology companies that shape the future by bringing innovative discoveries from research labs to commercial deployment.

Subscribe to the VIC newsletter.

Privacy Policy